AI-generated summary
This document reports four double-blind randomised controlled trials testing add-on treatments to antidepressants in major depression: bright light, pindolol, pulsed electromagnetic field (PEMF) and sleep-wake manipulation. The authors report that bright light was associated with higher response and remission at five weeks, but the difference was not sustained after four more weeks. Pindolol did not augment venlafaxine overall, PEMF was associated with greater score reductions than sham, and wake therapy was associated with better outcomes than exercise during the study.
- Studies included
- 4
- Who or what was studied
- Adults with major depression (DSM-IV), including bipolar depressive episodes; some PEMF patients were treatment resistant
- Limits stated in the abstract
- The abstract describes several separate trials with differing designs, subgroup analyses and an unsustained light effect, and it gives no total participant count.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Depression, Sham, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.